gross-to-net
(3)
IntegriChain and the money between the medicine
A drug can clear the laboratory and still get tangled in the business of reaching patients. IntegriChain connects the contracts, claims and data that decide what happens next.
Kalderos Found a $1 Billion Leak in America’s Drug-Discount Plumbing
Drug discounts are supposed to lower costs. The data underneath them is so fragmented that the same prescription can trigger multiple concessions. Kalderos built the reconciliation layer - and in 2026, Model N bought it.
Model N
Model N is a Redwood City-based enterprise software company that builds cloud revenue-management systems for pharmaceutical, medtech, semiconductor, and high-tech manufacturers. Its Revenue Cloud automates pricing, quoting, contracting, rebates, incentives, and regulatory compliance - the commercial machinery that governs how life sciences and high-tech companies book and protect their top line. Founded in 1999 and taken public in 2013, Model N was acquired by Vista Equity Partners in 2024 for $1.25 billion and now serves 150+ leading brands across more than 120 countries.